jRCTs041220164Recruiting
Untitled Trial
A phase II study of mFOLFOX6+Nivolumab as first line treatment in gastric cancer with severe peritoneal metastasis (WJOG16322G)
Japan Registry Clinical Trial
VerifiedJapan Registry Clinical Trial
Study focus
- Disease/Condition
- gastric cancer
- Study type
- Interventional
Sponsor & location
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Gastric ulcerMalignant neoplasm of stomachMalignant neoplasm: Body of stomachCarcinoma in situ: StomachMalignant neoplasm: Stomach, unspecified
Data source
- Registry
- Japan Registry Clinical Trial
- Trial ID
- jRCTs041220164
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for jRCTs041220164 through Pure Global AI's free database. This phase not specified trial is sponsored by sponsor not specified and is currently Recruiting. The study focuses on gastric cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.